UNSPSC 51282954: Enoxacin sesquihydrate

This classification denotes an anti-infective agent 2C15H17FN4O3.3H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I9CD31N8WB, chemically known as 1,8-naphthyridine-3-carboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, hydrate (2:3), but more generally known as enoxacin sesquihydrate, which bears US NIH Compound Identifier 3229. European Medicines Agency schedules SUB13675MIGin its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13675MIG.

Most nations schedule enoxacin sesquihydrate under HS 29335995 and SITC 51576. As of Q4 2014, ENOXACIN SESQUIHYDRATE remains the US FDA Preferred Term for this commodity. SMILES: CCN1CC(C(=O)C2C1NC(C(C2)F)N3CCNCC3)C(=O)O.CCN1CC(C(=O)C2C1NC(C(C2)F)N3CCNCC3)C(=O)O.O.O.O.

UNSPSC 51282954 Enoxacin sesquihydrate is a Commodity code covering a specific antibiotic pharmaceutical product. The code shows limited recent state and local procurement activity. The two most recent opportunities on file involve pharmaceutical procurement by public health and county agencies, but neither directly solicits enoxacin sesquihydrate; instead, they target other pharmaceutical products and medical supplies — the Illinois Department of Public Health awarded a contract for doxycycline hyclate and ciprofloxacin hydrochloride tablets, and Seminole County, Florida sought naloxone and drug deactivation systems. State and local procurement under this code appears to flow through cooperative purchasing vehicles such as MMCAP Infuse and through county IFB processes when pharmaceutical suppliers are engaged.

Geographic activity is limited to data from Illinois and Florida in the recent record. The Illinois Department of Public Health and Seminole County, Florida are the identified issuing bodies, representing a state health department and a county government respectively. The code does not show a pattern of repeat activity or concentrated solicitation activity sufficient to characterize momentum or buyer concentration. Enoxacin sesquihydrate procurement at the state and local level does not appear active in the current window; business development professionals should verify whether direct solicitations for this specific antibiotic exist through primary state and local procurement portals or cooperative purchasing consortiums before committing pursuit resources.